The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review | Zendy

B. Dingle | Zendy; R. Bryan Rumble | Zendy; Melissa Brouwers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review

Author(s) -

B. Dingle,

R. Bryan Rumble,

Melissa Brouwers

Publication year - 2005

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2005/565479

Subject(s) - gemcitabine , medicine , gallbladder cancer , capecitabine , oncology , guideline , gallbladder , cancer , randomized controlled trial , chemotherapy , gastrointestinal cancer , radiation therapy , clinical trial , general surgery , colorectal cancer , pathology

Cholangiocarcinoma and gallbladder cancer are difficult to treat curatively. The treatment of choice is surgery, dependent on detection at a resectable stage. No chemotherapy or radiotherapy options have shown substantial activity. Gemcitabine has demonstrated response in similar cancers. Considering the lack of treatment options for cholangiocarcinoma and gallbladder cancer, a systematic review of the evidence on gemcitabine use for these indications was performed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research